Inogen Inc (INGN) Files Form 4 Insider Selling : Matt Scribner Sells 4,102 Shares

Inogen Inc (INGN): Matt Scribner , EVP, Operations of Inogen Inc sold 4,102 shares on Jul 18, 2016. The Insider selling transaction was reported by the company on Jul 20, 2016 to the Securities and Exchange Commission. The shares were sold at $50.50 per share for a total value of $206,966.67 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 20, 2016, Raymond Huggenberger (CEO) sold 20,747 shares at $50.57 per share price.On Jun 20, 2016, Matt Scribner (EVP, Operations) sold 4,102 shares at $47.91 per share price.Also, On Apr 14, 2016, Brenton Taylor (EVP, Engineering) sold 6,500 shares at $48.00 per share price.On Apr 7, 2016, Alison Bauerlein (EVP, Finance & CFO) sold 9,278 shares at $46.17 per share price.

Shares of Inogen Inc (INGN) ended Monday, Jul 18, 2016 session in red amid volatile trading. The shares closed down -0.34 points or -0.67% at $50.34 with 1,54,543 shares getting traded. Post opening the session at $50.89, the shares hit an intraday low of $49.6 and an intraday high of $51.06 and the price vacillated in this range throughout the day. The company has a market cap of $1,003 M and the number of outstanding shares has been calculated to be 1,99,15,360 shares. The 52-week high of Inogen Inc is $55.98 and the 52-week low is $28.814.

Inogen Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Inogen Inc is Resumed by JP Morgan to Overweight. The Rating was issued on Jul 13, 2016.Inogen Inc is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 52 from a previous price target of $46 .The Rating was issued on May 10, 2016.Inogen Inc is Reiterated by Needham to Strong Buy and the brokerage firm has raised the Price Target to $ 58 from a previous price target of $47 .The Rating was issued on May 10, 2016.

Inogen Inc. is a medical technology company. The Company is engaged in developing manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company’s Inogen One G2 is effective for nocturnal use.

Leave a Reply

Inogen Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Inogen Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.